ReNAgade NEWS & PRESS RELEASES

We’re rapidly and relentlessly advancing transformational RNA medicines.

See the headlines our progress has inspired.

May 2023

ReNAgade Therapeutics Launches with Over $300 Million in Series A Financing to Unlock the Limitless Potential of RNA Medicine

Read More

“RNA without limits”, “Deliver-Code-Edit-Insert” are trademarks of ReNAgade Therapeutics, Inc.